DK0600873T3 - Terapeutisk virksom topisk anvendelse af ST1435 - Google Patents

Terapeutisk virksom topisk anvendelse af ST1435

Info

Publication number
DK0600873T3
DK0600873T3 DK91912052.7T DK91912052T DK0600873T3 DK 0600873 T3 DK0600873 T3 DK 0600873T3 DK 91912052 T DK91912052 T DK 91912052T DK 0600873 T3 DK0600873 T3 DK 0600873T3
Authority
DK
Denmark
Prior art keywords
therapeutically effective
topical application
effective topical
skin
blood
Prior art date
Application number
DK91912052.7T
Other languages
Danish (da)
English (en)
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of DK0600873T3 publication Critical patent/DK0600873T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK91912052.7T 1990-06-01 1991-05-24 Terapeutisk virksom topisk anvendelse af ST1435 DK0600873T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01

Publications (1)

Publication Number Publication Date
DK0600873T3 true DK0600873T3 (da) 1997-05-20

Family

ID=24120850

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91912052.7T DK0600873T3 (da) 1990-06-01 1991-05-24 Terapeutisk virksom topisk anvendelse af ST1435
DK96201585T DK0754456T3 (da) 1990-06-01 1991-05-24 Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK96201585T DK0754456T3 (da) 1990-06-01 1991-05-24 Forberedelse af sammensætninger der omfatter ST1435 til topisk anvendelse

Country Status (10)

Country Link
US (1) US5651973A (de)
EP (3) EP0600873B1 (de)
JP (1) JP2625254B2 (de)
AT (2) ATE220912T1 (de)
CA (1) CA2083404C (de)
DE (2) DE69125855T2 (de)
DK (2) DK0600873T3 (de)
ES (2) ES2099747T3 (de)
GR (1) GR3023312T3 (de)
WO (1) WO1991018570A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018570A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Therapeutically effective topical application of st1435
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US8529807B2 (en) * 2002-01-17 2013-09-10 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
WO2010019365A1 (en) * 2008-08-12 2010-02-18 Optimer, Inc. Method of reducing the distortion of the electromagnetic field
CN102753180A (zh) 2009-12-17 2012-10-24 人口委员会股份有限公司 Nestorone*/雌二醇透皮凝胶
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
EP3224410B1 (de) 2014-11-25 2019-06-05 Buckman Laboratories International, Inc Filzkonditionierer und -reiniger

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (de) * 1969-02-13 1970-08-17
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
EP0394429B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend gestoden
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
WO1991018570A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Therapeutically effective topical application of st1435
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
EP0754456A3 (de) 2000-02-02
DE69125855D1 (de) 1997-05-28
EP0754456B1 (de) 2002-07-24
EP0600873B1 (de) 1997-04-23
DE69133077D1 (de) 2002-08-29
DK0754456T3 (da) 2002-11-11
US5651973A (en) 1997-07-29
DE69125855T2 (de) 1997-07-31
JP2625254B2 (ja) 1997-07-02
CA2083404C (en) 2001-02-20
EP1093816A3 (de) 2003-10-22
EP0754456A2 (de) 1997-01-22
CA2083404A1 (en) 1991-12-02
ES2099747T3 (es) 1997-06-01
EP0600873A4 (de) 1993-09-02
ES2180690T3 (es) 2003-02-16
WO1991018570A1 (en) 1991-12-12
JPH07502253A (ja) 1995-03-09
ATE220912T1 (de) 2002-08-15
ATE151977T1 (de) 1997-05-15
GR3023312T3 (en) 1997-08-29
EP0600873A1 (de) 1994-06-15
EP1093816A2 (de) 2001-04-25
DE69133077T2 (de) 2002-11-07

Similar Documents

Publication Publication Date Title
World Health Organization The World health report: 1997: Conquering suffering, enriching humanity
DK0600873T3 (da) Terapeutisk virksom topisk anvendelse af ST1435
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
DK0719145T3 (da) Nitrogenoxiddonorpræparat til behandling af anale lidelser
DK0605484T3 (da) Peptider med væksthormonfrigørende aktivitet
DK0682514T3 (da) Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma
TR200002179T2 (tr) Kristalin teriparatid.
ATE107517T1 (de) Transdermales therapeutisches mittel.
SE7514589L (sv) Aminosyrapreparat for patienter med leversjukdom och sett att anvenda dessa preparat
PT933993E (pt) Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
DK0378086T3 (da) Anvendelse af det aktive stof azelastin til bekæmpelse af psoriasis-sygdomme
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
DK254887A (da) Salve til behandling af hudsygdomme
IT1057132B (it) Bendaggio stratificato per la somministrazione di scopolamina per via transdermica
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
ES2081952T3 (es) Procedimiento para la preparacion de soluciones de albumina purificada.
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
IT1318667B1 (it) Medicamento antinfiammatorio.
IT1254521B (it) Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
DK0509120T3 (da) Topisk anvendelse af glycosaminoglycaner til forebyggelse og behandling af sygdomme, der påvirker det cervikale vaginale område
NL7804192A (nl) Cyclohexaancarbonzuur en de derivaten hiervan, evenals de toepassing van deze stoffen als therapeutisch mid- del.
IE780497L (en) Broparestrol based therapeutic compositions
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
ATE435023T1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
DK295378A (da) Fremgangsmaade til fremstilling af terapeutisk virksomme diarylalkylaminer